Search

Search Results
Results 18151 - 18160 of 18997 for stroke
  • Drug - 19 Feb 2025
    Consumer Medicine Information (CMI) about Tranexamic Acid intended for persons living in Australia.
  • News - 18 Feb 2025
    Japan’s salt reduction efforts have lowered sodium intake over decades, but levels remain high, prompting economic modeling to assess the impact of stricter policies on cardiovascular disease and...
  • Drug - 13 Feb 2025
    Consumer Medicine Information (CMI) about Ralovera intended for persons living in Australia.
  • Drug - 13 Feb 2025
    Consumer Medicine Information (CMI) about Provera intended for persons living in Australia.
  • Drug - 21 Jan 2025
    Consumer Medicine Information (CMI) about Uptravi intended for persons living in Australia.
  • Drug - 15 Jan 2025
    Consumer Medicine Information (CMI) about Omjjara intended for persons living in Australia.
  • Drug - 9 Jan 2025
    Consumer Medicine Information (CMI) about Velsipity intended for persons living in Australia.
  • Drug - 7 Jan 2025
    Consumer Medicine Information (CMI) about Tryzan intended for persons living in Australia.
  • News - 2 Jan 2025
    This week, KFF Health News' "What the Health?" presents a conversation with Francis Collins, former National Institutes of Health director and White House science adviser.
  • Drug - 19 Dec 2024
    Consumer Medicine Information (CMI) about Strattera (atomoxetine hydrochloride) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.